3,4-dihydroxyphenylacetic acid has been researched along with Nephrosis, Lipoid in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pestana, M | 1 |
| Jardim, H | 1 |
| Afonso, C | 1 |
| Serrão, P | 1 |
| Santos, N | 1 |
| Guerra, L | 1 |
| Soares-da-Silva, P | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Nephrosis, Lipoid
| Article | Year |
|---|---|
Renal dopaminergic system in nephrotic syndrome and after remission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Child; Dopamine; Drug Therapy, Combination; Edema; Female; Follow-Up | 1998 |